AJMC® in the Press, August 12, 2022

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A study published in the August 2022 issue of The American Journal of Managed Care® (AJMC®) was cited in an article by Medical Xpress. The study, “Formulary Restrictions and Stroke Risk in Patients With Atrial Fibrillation,” indicated that limited access to non–vitamin K antagonist oral anticoagulants due to step therapy and prior authorization requirements may exacerbate current underuse of anticoagulants and increase stroke risk in patients with newly diagnosed atrial fibrillation.

A piece by Forbes referenced a video interview published on AJMC.com, the website of AJMC®. The video interview, titled, “Ted Kyle Explains How Public Stigma Hinders Obesity Treatment,” addressed how stigma and bias surrounding obesity hinders the ability to improve affected patients’ health.

Another study published in the August 2022 issue of AJMC® was cited in an article by El Paso Inc. The study, “A Kidney Diagnostic’s Impact on Physician Decision-Making in Diabetic Kidney Disease,” showed that primary care physicians would use the results of the KidneyIntelX test more than albuminuria and estimated glomerular filtration rate when making decisions about diabetic kidney disease management.

A study published in the June 2022 issue of AJMC® titled, “A Scoping Review of US Insurers’ Use of Patient-Reported Outcomes,” was referenced in an article by InsuranceNewsNet. The study reviewed US health insurers’ use of health-related quality of life patient-reported outcome measures and found there is a paucity of data in pediatric populations and little information about the use of data collected within health care settings that is transmitted to health insurers.

Related Videos
Related Content
© 2023 MJH Life Sciences
All rights reserved.